Sign In

Explore Latest News

Explore significant articles on advancements and research in cancer treatment.

Sign Up

BREAKWATER Trial Highlights Importance Of Early Biomarker Testing In Colon Cancer

Kavontae Smalls

Adding PARP Inhibitor Niraparib To Standard Improves Outcomes For Advanced Prostate Cancer With HRR Gene Mutation

'Practice-Changing' Combination Treatment Shows Promise For Triple-Negative Breast Cancer — Unpacking The New Data

Osimertinib (Tagrisso) Leads To More Tumor Shrinkage For EGFR+ Lung Cancer Patients

Kavontae Smalls

Adding Durvalumab Keeps Gastric Cancer Under Control Longer, MATTERHORN Trial Shows

Dr. Rodrigo C. Leão Edelmuth

The DESTINY Trial Confirms Top Second-Line Approach For HER2+ Advanced Gastric Cancer

Dr. Rodrigo C. Leão Edelmuth

DESTINY Updates: New Drug Combo May Keep HER2+ Metastatic Breast Cancer Under Control For Longer

A Better Option For Some Women With Advanced HR+, HER2- Breast Cancer: Unpacking The SERENA-6 Trial

Dr. Rodrigo C. Leão Edelmuth

How Will Federal Budget Cuts Affect The Future Of Cancer Research?

Load more